Stem Cell Treatment for Type 1 Diabetes
May 7, 2010 |
Osiris Therapeutics announced that it has been granted Orphan Drug designation from the U.S. Food and Drug Administration (FDA) for Prochymal as a treatment for type 1 diabetes mellitus. The FDA instituted the Orphan Drug Act to promote the development of treatments for underserved patient populations. To be eligible for Orphan Drug designation, the treatment must target a disease that affects fewer than 200,000 new patients per year in the United States.
Oy! Cutting Calories May Actually Make You Put on Pounds
Patrick Totty |
Apr 29, 2010 |
-SIGH- A pessimist might say that the following news is another sign that Mother Nature sometimes has one mean sense of humor: Reducing your caloric intake in order to lose weight may, ironically, lead to weight gain.
Lee Zhong, M.D., Ph.D.
Introducing Glucocil, a new Dietary Supplement that has shown promising results controlling post meal blood sugar levels.
UK Study Says Bisphenol A (BPA) Is Connected to Increased Risks for Diabetes and Coronary Heart Disease
Patrick Totty |
Feb 2, 2010 |
A study by researchers at the universities of Exeter and Plymouth in the United Kingdom says that Bisphenol A-BPA-a chemical commonly used in plastic packaging and products, is associated with an increased risk of diabetes and coronary heart disease.
ProtoKinetix Anti-Aging Glycopeptides Show Promise Against Diabetes
Russell Phillips, PhD |
Jan 13, 2010 |
One potential avenue for the treatment for type 1 diabetes is to transplant insulin-producing islet cells into the body. The Edmonton Protocol is a method of implanting pancreatic islets into the liver for the treatment of type 1 diabetes. The protocol is named for the islet transplantation group at the University of Alberta in Edmonton, Canada, where the protocol was first devised in the late 1990s.
Eliminating Endocrinologist Consultations
Dec 15, 2009 |
JACKSONVILLE, Fla., Dec. 7 -- A survey just conducted by the American Association of Clinical Endocrinologists (AACE) indicates that the Centers for Medicare & Medicaid Services (CMS) decision to eliminate consultation codes will force four out of five endocrinologists to reduce the number of Medicare patients seen in their practices.
Supply and Demand
Amy Mercer |
Jan 21, 2009 |
The treatment of diabetes has come a long way since Dr. Elliot Joslin wrote The Treatment of Diabetes Mellitus in 1916. But Dr. Joslin's idea that diet, exercise, and insulin (when it became available as therapy in 1922) are the keys to managing diabetes remains true today. This doesn't mean that diabetes is not a complex illness requiring ongoing education and individualized care. People with diabetes benefit greatly from the services of a team of health care professionals including a certified diabetes educator and an endocrinologist--a doctor who specializes in treating disorders of the endocrine system.
Diabetes Health Medical Disclaimer
The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.